Structural biology in antiviral drug discovery
- PMID: 27611878
- PMCID: PMC7185576
- DOI: 10.1016/j.coph.2016.08.014
Structural biology in antiviral drug discovery
Abstract
Structural biology has emerged during the last thirty years as a powerful tool for rational drug discovery. Crystal structures of biological targets alone and in complex with ligands and inhibitors provide essential insights into the mechanisms of actions of enzymes, their conformational changes upon ligand binding, the architectures and interactions of binding pockets. Structure-based methods such as crystallographic fragment screening represent nowadays invaluable instruments for the identification of new biologically active compounds. In this context, three-dimensional protein structures have played essential roles for the understanding of the activity and for the design of novel antiviral agents against several different viruses. In this review, the evolution in the resolution of viral structures is analysed, along with the role of crystal structures in the discovery and optimisation of new antivirals.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Editorial overview: Engineering for viral resistance.Curr Opin Virol. 2015 Oct;14:v-vii. doi: 10.1016/j.coviro.2015.08.009. Epub 2015 Aug 28. Curr Opin Virol. 2015. PMID: 26320757 Free PMC article. No abstract available.
-
Editorial overview: antivirals and resistance: advances and challenges ahead.Curr Opin Virol. 2014 Oct;8:iv-vii. doi: 10.1016/j.coviro.2014.08.002. Epub 2014 Aug 22. Curr Opin Virol. 2014. PMID: 25155454 Free PMC article. No abstract available.
-
A prospects tool in virus research: Analyzing the applications of organoids in virus studies.Acta Trop. 2024 Jun;254:107182. doi: 10.1016/j.actatropica.2024.107182. Epub 2024 Mar 11. Acta Trop. 2024. PMID: 38479469 Review.
-
Recent progresses in marine microbial-derived antiviral natural products.Arch Pharm Res. 2020 Dec;43(12):1215-1229. doi: 10.1007/s12272-020-01286-3. Epub 2020 Nov 21. Arch Pharm Res. 2020. PMID: 33222073 Free PMC article. Review.
-
Human viral diseases: what is next for antiviral drug discovery?Curr Opin Virol. 2012 Oct;2(5):572-9. doi: 10.1016/j.coviro.2012.07.004. Epub 2012 Jul 28. Curr Opin Virol. 2012. PMID: 22846888 Review.
Cited by
-
In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors.Sci Rep. 2019 May 2;9(1):6809. doi: 10.1038/s41598-019-43129-2. Sci Rep. 2019. PMID: 31048746 Free PMC article.
-
A Literature Review Focusing on the Antiviral Activity of [1,2,4] and [1,2,3]-triazoles.Mini Rev Med Chem. 2024;24(17):1602-1629. doi: 10.2174/0113895575277122231108095511. Mini Rev Med Chem. 2024. PMID: 38008942 Review.
-
Non-nucleoside structured compounds with antiviral activity-past 10 years (2010-2020).Eur J Med Chem. 2022 Mar 5;231:114136. doi: 10.1016/j.ejmech.2022.114136. Epub 2022 Jan 19. Eur J Med Chem. 2022. PMID: 35085926 Free PMC article. Review.
References
-
- Blundell T.L., Jhoti H., Abell C. High-throughput crystallography for lead discovery in drug design. Nat Rev Drug Discov. 2002;1:45–54. - PubMed
-
- Howard J.A. Dorothy hodgkin and her contributions to biochemistry. Nat Rev Mol Cell Biol. 2003;4:891–896. - PubMed
-
- Tang L., Johnson J.E. Structural biology of viruses by the combination of electron cryomicroscopy and X-ray crystallography. Biochemistry. 2002;41:11517–11524. - PubMed
-
- Talele T.T., Khedkar S.A., Rigby A.C. Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. Curr Top Med Chem. 2010;10:127–141. - PubMed
-
- Congreve M., Murray C.W., Blundell T.L. Structural biology and drug discovery. Drug Discov Today. 2005;10:895–907. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources